Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3065
The Immunoscore: Colon Cancer and Beyond
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-1851
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3661
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3944
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1425
Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-2521
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1237
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3468
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0253
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0361
IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3458
Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3818
Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3477
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3991
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3511
Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non–small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-2702
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0836
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-2847
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0114
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-2214
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0851
HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody–Drug Conjugate Drug Development in Solid Tumors
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-1976
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1614
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-17-3024
Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [18F]FLT and [18F]ISO-1 PET/CT
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-2769
Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1567
Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3669
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0526
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-3470
Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0628
DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-2180
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1255
Oncogenic NRG1 Fusions: A New Hope for Targeted Therapy in Pancreatic Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1280
Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe)
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3755
A PI3K/AKT Scaffolding Protein, IQ Motif–Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1063
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0389
Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-18-3453
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1069
BRAF Inhibition: Bridge or Boost to T-cell Therapy?
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0286
Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance—Letter
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-0164
MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1611
Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1800
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-2962
Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-2742
Abstract AP16: MODELING ENDOMETRIOID AND HIGH GRADE SEROUS CARCINOMAS IN THE MOUSE USING CRISPR/CAS9-MEDIATED SOMATIC GENE EDITING IN FALLOPIAN TUBE EPITHELIUM
来源期刊：Clinical Cancer ResearchDOI：10.1158/1557-3265.OVCASYMP18-AP16
Abstract GMM-041: OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
来源期刊：Clinical Cancer ResearchDOI：10.1158/1557-3265.OVCASYMP18-GMM-041
AACR Cancer Progress Report 2019: Transforming Lives Through Innovative Cancer Science
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.ccr-19-2655
Abstract DP-013: DEVELOPMENT AND VALIDATION OF CIRCULATING CA125 PREDICTION MODEL IN POSTMENOPAUSAL WOMEN WITHOUT OVARIAN CANCER
来源期刊：Clinical Cancer ResearchDOI：10.1158/1557-3265.OVCASYMP18-DP-013
Quantitative Ultrasound Spectroscopy for Differentiation of Hepatocellular Carcinoma from At-Risk and Normal Liver Parenchyma
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-1030
A Solution to the Dilution: The Role for Biomarkers in Advanced Ovarian Cancer
来源期刊：Clinical Cancer ResearchDOI：10.1158/1078-0432.CCR-19-3072
投稿咨询
加急服务
论文发表
2-4个月录用
7500+文章录用
不成功可退款
